Nurse Practitioner, Family · Portland, OR
NPI
1972892693
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-7772
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,563
100 services
Medicare patients, 2024
42
Average age 52
Drug cost, 2024
$486K
2,042 prescriptions
Company payments, 2025
$145
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen M Medwar was code 99214 (office e&m - established), 21 times for 18 patients. In total Kathleen M Medwar billed 100 services in 9 codes, and Medicare paid $4,563.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 21 | 18 | $55.44 | $1,164 |
| 99215 Office E&M - Established | Office | 20 | 13 | $74.51 | $1,490 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 12 | $11.00 | $154 |
| 99214 Office E&M - Established | Facility | 12 | 11 | $45.88 | $551 |
By year: 2022 $5,341 for 113 services; 2023 $6,464 for 120 services; 2024 $4,563 for 100 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen M Medwar prescribed most often to Medicare patients was Lamotrigine, with 291 prescriptions and refills. In total Kathleen M Medwar wrote 2,042 Medicare prescriptions that cost $486K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 291 | 370 | 36 | $5,504 |
| Clobazam Generic | 242 | 274 | 37 | $19K |
| Lacosamide Generic | 190 | 221 | 31 | $17K |
| Levetiracetam Generic | 162 | 253 | 26 | $7,048 |
| Clonazepam Generic | 133 | 136 | 21 | $1,417 |
| Topiramate Generic | 94 | 124 | 14 | $1,519 |
| Gabapentin Generic | 91 | 136 | 15 | $5,249 |
| Zonisamide Generic | 86 | 141 | 18 | $2,793 |
| Levetiracetam Er Levetiracetam | 51 | 73 | Under 11 | $2,629 |
| Lorazepam Generic | 42 | 43 | 21 | $110 |
| Lamotrigine Er Lamotrigine | 40 | 54 | Under 11 | $17K |
| Xcopri Cenobamate | 39 | 39 | Under 11 | $46K |
| Divalproex Sodium Er Divalproex Sodium | 36 | 54 | Under 11 | $1,127 |
| Oxcarbazepine Generic | 35 | 50 | Under 11 | $6,850 |
| Carbamazepine Er Carbamazepine | 30 | 42 | Under 11 | $2,788 |
Brand drugs: - claims; generic drugs: 1,838 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen M Medwar $145 ($145 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $145.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.